Question 1

What specific educational materials will be provided to help with medication adherence?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO) clinical trial (NCT06232603). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my participation in this study be monitored?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO) clinical trial (NCT06232603). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of surveys will I need to complete, and how often?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO) clinical trial (NCT06232603). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any risks or downsides to participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO) clinical trial (NCT06232603). Contact the study team or your healthcare provider for specific answers.

Question 5

How will this study help improve my treatment for CRMO?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO) clinical trial (NCT06232603). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I decide to withdraw from the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO) clinical trial (NCT06232603). Contact the study team or your healthcare provider for specific answers.

What this study is about